Roadmap Epigenomics Consortium

The Roadmap Epigenomics Consortium is an international research effort that maps the chemical markers on DNA called epigenetic modifications across different human tissues and cell types. These markers influence gene activity without changing the underlying DNA sequence, helping us understand how genes are turned on or off in health and disease. By creating detailed epigenomic maps, the consortium aims to advance personalized medicine, improve understanding of complex diseases like cancer, and facilitate the development of targeted treatments. This comprehensive resource enhances our knowledge of human biology and disease mechanisms at the molecular level.